Panel Discussion: Error Proofing Your Pharmacy - Featured in this episode: Fred Mayer - Drug Topics

ADVERTISEMENT

Panel Discussion: Error Proofing Your Pharmacy - Featured in this episode: Fred Mayer
Drug Topics Radio

logo

line
spacer
 starburstPanel Discussion: Error Proofing Your Pharmacy
(Featured Speaker: Fred Mayer)
 
spacer
line
spacer
podcast faqSubscribe to the Podcast

Judy Chi, Editor-in-Chief of Drug Topics, moderates a panel discussion on Error Proofing Your Pharmacy. Panelists include Lyle Bootman of the University of Arizona, Michael Cohen of The Institute for Safe Medication Practices, David Fong of Safeway, JIm Jorgenson of the University of Utah, Susan Ravnan of the California State Board of Pharmacy, Fred Mayer of the Pharmacists Planning Service Inc. and Joe Laborsky, Publisher of Drug Topics.

 
xml
itunes
Add to Google
download
spacer
To listen to a previous podcast, click a play button below:
spacer
pod4
pod4
pod3
podcast2
podcast1
spacer
line
spacer
Comments/Questions?
Email Address:
Comments:
 
line
Drug Topics podcasts are developed and produced by DRUGTOPICS.COM, a division of Advanstar Communications, Inc., which is solely responsible for podcast content.
 
Drug Topics issue
Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION

ADVERTISEMENT

Survey
What is the biggest issue facing pharmacy in 2009?
The economy
Diabetic drug approvals
Medicaid/Medicare
Your salary/benefits
View Results
The economy
45%
Diabetic drug approvals
2%
Medicaid/Medicare
38%
Your salary/benefits
15%
View Results

Modern Medicine logoDrug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Click here